A citation-based method for searching scientific literature

Jordy C G van der Zwet, Jessica G C A M Buijs-Gladdines, Valentina Cordo', Donna O Debets, Willem K Smits, Zhongli Chen, Jelle Dylus, Guido J R Zaman, Maarten Altelaar, Koichi Oshima, Beat Bornhauser, Jean-Pierre Bourquin, Jan Cools, Adolfo A Ferrando, Josef Vormoor, Rob Pieters, Britta Vormoor, Jules P P Meijerink. Leukemia 2021
Times Cited: 9







List of co-cited articles
54 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
Yunlei Li, Jessica G C A M Buijs-Gladdines, Kirsten Canté-Barrett, Andrew P Stubbs, Eric M Vroegindeweij, Willem K Smits, Ronald van Marion, Winand N M Dinjens, Martin Horstmann, Roland P Kuiper,[...]. PLoS Med 2016
73
55

IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias.
Ana Silva, Angelo B A Laranjeira, Leila R Martins, Bruno A Cardoso, Jocelyne Demengeot, J Andrés Yunes, Benedict Seddon, João T Barata. Cancer Res 2011
103
44

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.
Jinghui Zhang, Li Ding, Linda Holmfeldt, Gang Wu, Sue L Heatley, Debbie Payne-Turner, John Easton, Xiang Chen, Jianmin Wang, Michael Rusch,[...]. Nature 2012
33

STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells.
Daniel Ribeiro, Alice Melão, Ruben van Boxtel, Cristina I Santos, Ana Silva, Milene C Silva, Bruno A Cardoso, Paul J Coffer, João T Barata. Blood Adv 2018
35
33

Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.
Stephen P Hunger, Xiaomin Lu, Meenakshi Devidas, Bruce M Camitta, Paul S Gaynon, Naomi J Winick, Gregory H Reaman, William L Carroll. J Clin Oncol 2012
714
33

Flip the coin: IL-7 and IL-7R in health and disease.
João T Barata, Scott K Durum, Benedict Seddon. Nat Immunol 2019
110
33

MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia.
K Canté-Barrett, J A P Spijkers-Hagelstein, J G C A M Buijs-Gladdines, J C M Uitdehaag, W K Smits, J van der Zwet, R C Buijsman, G J R Zaman, R Pieters, J P P Meijerink. Leukemia 2016
65
33

Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia.
Guillaume Richard-Carpentier, Elias Jabbour, Nicholas J Short, Caitlin R Rausch, Jonathan M Savoy, Prithviraj Bose, Musa Yilmaz, Nitin Jain, Gautam Borthakur, Maro Ohanian,[...]. Clin Lymphoma Myeloma Leuk 2020
43
22

Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.
Nitin Jain, Audrey V Lamb, Susan O'Brien, Farhad Ravandi, Marina Konopleva, Elias Jabbour, Zhuang Zuo, Jeffrey Jorgensen, Pei Lin, Sherry Pierce,[...]. Blood 2016
167
22

mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia.
David T Teachey, Cecilia Sheen, Junior Hall, Theresa Ryan, Valerie I Brown, Jonathan Fish, Gregor S D Reid, Alix E Seif, Robin Norris, Yueh J Chang,[...]. Blood 2008
88
22

Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia.
Pedro J Real, Valeria Tosello, Teresa Palomero, Mireia Castillo, Eva Hernando, Elisa de Stanchina, Maria Luisa Sulis, Kelly Barnes, Catherine Sawai, Irene Homminga,[...]. Nat Med 2009
331
22

Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study.
Anna Candoni, Davide Lazzarotto, Felicetto Ferrara, Antonio Curti, Federico Lussana, Cristina Papayannidis, Maria Ilaria Del Principe, Massimiliano Bonifacio, Federico Mosna, Mario Delia,[...]. Am J Hematol 2020
19
22

Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphoma.
Martin H Cohen, John R Johnson, Tristan Massie, Rajeshwari Sridhara, W David McGuinn, Sophia Abraham, Brian P Booth, M Anwar Goheer, David Morse, Xiao H Chen,[...]. Clin Cancer Res 2006
55
22

Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.
Daniel J DeAngelo, Daohai Yu, Jeffrey L Johnson, Steven E Coutre, Richard M Stone, Alison T Stopeck, Jon P Gockerman, Beverly S Mitchell, Frederick R Appelbaum, Richard A Larson. Blood 2007
186
22

High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation.
Nicola Gökbuget, Nadezda Basara, Herrad Baurmann, Joachim Beck, Monika Brüggemann, Helmut Diedrich, Björn Güldenzoph, Gernot Hartung, Heinz-August Horst, Andreas Hüttmann,[...]. Blood 2011
114
22

Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.
Hagop M Kantarjian, Daniel J DeAngelo, Matthias Stelljes, Giovanni Martinelli, Michaela Liedtke, Wendy Stock, Nicola Gökbuget, Susan O'Brien, Kongming Wang, Tao Wang,[...]. N Engl J Med 2016
720
22

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.
Andrew P Weng, Adolfo A Ferrando, Woojoong Lee, John P Morris, Lewis B Silverman, Cheryll Sanchez-Irizarry, Stephen C Blacklow, A Thomas Look, Jon C Aster. Science 2004
22

Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group.
Stacey L Berg, Susan M Blaney, Meenakshi Devidas, Tom A Lampkin, Anthony Murgo, Mark Bernstein, Amy Billett, Joanne Kurtzberg, Greg Reaman, Paul Gaynon,[...]. J Clin Oncol 2005
197
22

T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993).
David I Marks, Elisabeth M Paietta, Anthony V Moorman, Susan M Richards, Georgina Buck, Gordon DeWald, Adolfo Ferrando, Adele K Fielding, Anthony H Goldstone, Rhett P Ketterling,[...]. Blood 2009
238
22

Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study.
Jonathan Bond, Carlos Graux, Ludovic Lhermitte, Diane Lara, Thomas Cluzeau, Thibaut Leguay, Agata Cieslak, Amélie Trinquand, Cedric Pastoret, Mohamed Belhocine,[...]. J Clin Oncol 2017
94
22

Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells.
Elodie M Kuntz, Pablo Baquero, Alison M Michie, Karen Dunn, Saverio Tardito, Tessa L Holyoake, G Vignir Helgason, Eyal Gottlieb. Nat Med 2017
260
22

Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization.
Stuart S Winter, Kimberly P Dunsmore, Meenakshi Devidas, Brent L Wood, Natia Esiashvili, Zhiguo Chen, Nancy Eisenberg, Nikki Briegel, Robert J Hayashi, Julie M Gastier-Foster,[...]. J Clin Oncol 2018
99
22

CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance.
Lauren A Pitt, Anastasia N Tikhonova, Hai Hu, Thomas Trimarchi, Bryan King, Yixiao Gong, Marta Sanchez-Martin, Aris Tsirigos, Dan R Littman, Adolfo A Ferrando,[...]. Cancer Cell 2015
171
22

Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.
Vinod A Pullarkat, Norman J Lacayo, Elias Jabbour, Jeffrey E Rubnitz, Ashish Bajel, Theodore W Laetsch, Jessica Leonard, Susan I Colace, Seong Lin Khaw, Shaun A Fleming,[...]. Cancer Discov 2021
56
22

Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition.
Julie Irving, Elizabeth Matheson, Lynne Minto, Helen Blair, Marian Case, Christina Halsey, Isabella Swidenbank, Frida Ponthan, Renate Kirschner-Schwabe, Stefanie Groeneveld-Krentz,[...]. Blood 2014
166
22

Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group.
Terzah M Horton, James A Whitlock, Xiaomin Lu, Maureen M O'Brien, Michael J Borowitz, Meenakshi Devidas, Elizabeth A Raetz, Patrick A Brown, William L Carroll, Stephen P Hunger. Br J Haematol 2019
37
22

Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study.
Yoav H Messinger, Paul S Gaynon, Richard Sposto, Jeannette van der Giessen, Elena Eckroth, Jemily Malvar, Bruce C Bostrom. Blood 2012
156
22

Glucocorticoid use in acute lymphoblastic leukaemia.
Hiroto Inaba, Ching-Hon Pui. Lancet Oncol 2010
211
22

IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.
R P Kuiper, E Waanders, V H J van der Velden, S V van Reijmersdal, R Venkatachalam, B Scheijen, E Sonneveld, J J M van Dongen, A J P Veerman, F N van Leeuwen,[...]. Leukemia 2010
199
22

Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia.
A Lonetti, I L Antunes, F Chiarini, E Orsini, F Buontempo, F Ricci, P L Tazzari, P Pagliaro, F Melchionda, A Pession,[...]. Leukemia 2014
53
22

Interleukin-7 in T-cell acute lymphoblastic leukemia: an extrinsic factor supporting leukemogenesis?
Joao T Barata, Angelo A Cardoso, Vassiliki A Boussiotis. Leuk Lymphoma 2005
55
22

Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199.
Triona Ni Chonghaile, Justine E Roderick, Cian Glenfield, Jeremy Ryan, Stephen E Sallan, Lewis B Silverman, Mignon L Loh, Stephen P Hunger, Brent Wood, Daniel J DeAngelo,[...]. Cancer Discov 2014
146
22

Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia.
P Richter-Pechańska, J B Kunz, J Hof, M Zimmermann, T Rausch, O R Bandapalli, E Orlova, G Scapinello, J C Sagi, M Stanulla,[...]. Blood Cancer J 2017
57
22


Tumor suppressor IKZF1 mediates glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia.
R Marke, J Havinga, J Cloos, M Demkes, G Poelmans, L Yuniati, D van Ingen Schenau, E Sonneveld, E Waanders, R Pieters,[...]. Leukemia 2016
44
22

IKZF1plus Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.
Martin Stanulla, Elif Dagdan, Marketa Zaliova, Anja Möricke, Chiara Palmi, Giovanni Cazzaniga, Cornelia Eckert, Geertruy Te Kronnie, Jean-Pierre Bourquin, Beat Bornhauser,[...]. J Clin Oncol 2018
125
22

Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia.
Erich Piovan, Jiyang Yu, Valeria Tosello, Daniel Herranz, Alberto Ambesi-Impiombato, Ana Carolina Da Silva, Marta Sanchez-Martin, Arianne Perez-Garcia, Isaura Rigo, Mireia Castillo,[...]. Cancer Cell 2013
174
22

Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias.
Chen Shochat, Noa Tal, Obul R Bandapalli, Chiara Palmi, Ithamar Ganmore, Geertruy te Kronnie, Gunnar Cario, Giovanni Cazzaniga, Andreas E Kulozik, Martin Stanulla,[...]. J Exp Med 2011
243
22

Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes.
Lauren K Meyer, Benjamin J Huang, Cristina Delgado-Martin, Ritu P Roy, Aaron Hechmer, Anica M Wandler, Tiffaney L Vincent, Paolo Fortina, Adam B Olshen, Brent L Wood,[...]. J Clin Invest 2020
25
22

JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias.
C Delgado-Martin, L K Meyer, B J Huang, K A Shimano, M S Zinter, J V Nguyen, G A Smith, J Taunton, S S Winter, J R Roderick,[...]. Leukemia 2017
74
22

Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells.
Joao T Barata, Ana Silva, Joana G Brandao, Lee M Nadler, Angelo A Cardoso, Vassiliki A Boussiotis. J Exp Med 2004
204
22

IKZF1 deletion is enriched in pediatric B-cell precursor acute lymphoblastic leukemia patients showing prednisolone resistance.
T Imamura, M Yano, D Asai, A Moriya-Saito, S-I Suenobu, D Hasegawa, T Deguchi, Y Hashii, H Kawasaki, H Hori,[...]. Leukemia 2016
9
22

Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.
Priscila P Zenatti, Daniel Ribeiro, Wenqing Li, Linda Zuurbier, Milene C Silva, Maddalena Paganin, Julia Tritapoe, Julie A Hixon, André B Silveira, Bruno A Cardoso,[...]. Nat Genet 2011
275
22

Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia.
S Degryse, C E de Bock, S Demeyer, I Govaerts, S Bornschein, D Verbeke, K Jacobs, S Binos, D A Skerrett-Byrne, H C Murray,[...]. Leukemia 2018
52
22

The genetics and molecular biology of T-ALL.
Tiziana Girardi, Carmen Vicente, Jan Cools, Kim De Keersmaecker. Blood 2017
166
22

Acute Lymphoblastic Leukemia in Children.
Stephen P Hunger, Charles G Mullighan. N Engl J Med 2015
936
22

Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group.
Rob Pieters, Hester de Groot-Kruseman, Vincent Van der Velden, Marta Fiocco, Henk van den Berg, Evelien de Bont, R Maarten Egeler, Peter Hoogerbrugge, Gertjan Kaspers, Ellen Van der Schoot,[...]. J Clin Oncol 2016
193
22

IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update.
Mariana L Oliveira, Padma Akkapeddi, Daniel Ribeiro, Alice Melão, João T Barata. Adv Biol Regul 2019
45
22

Cell biology of IL-7, a key lymphotrophin.
Qiong Jiang, Wen Qing Li, Francesca B Aiello, Renata Mazzucchelli, Benyam Asefa, Annette R Khaled, Scott K Durum. Cytokine Growth Factor Rev 2005
251
22



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.